RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Standard Chem & Pharm Co - Stock

Standard Chem & Pharm Co Revenue 2024

Standard Chem & Pharm Co Revenue

6.94 B TWD

Ticker

1720.TW

ISIN

TW0001720001

In 2024, Standard Chem & Pharm Co's sales reached 6.94 B TWD, a 11.21% difference from the 6.24 B TWD sales recorded in the previous year.

The Standard Chem & Pharm Co Revenue history

YEARREVENUE (undefined TWD)GROSS MARGIN (%)
2024e6.9439,28
20236.2443,68
20225.8542,51
20214.644,91
20204.3144,59
20193.9443,41
20183.5743,23
20173.8545,44
20163.6742,91
20153.3245,01
20143.343,93
20133.0542,49
20123.3738,97
20113.3339,98
20102.8942,49
20092.2845,92
20082.1848,73
20072.0150,88
20061.9252,56
20051.6853,16
20041.5251,91

Standard Chem & Pharm Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Standard Chem & Pharm Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Standard Chem & Pharm Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Standard Chem & Pharm Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Standard Chem & Pharm Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Standard Chem & Pharm Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Standard Chem & Pharm Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Standard Chem & Pharm Co’s growth potential.

Standard Chem & Pharm Co Revenue, EBIT and net profit per share

DateStandard Chem & Pharm Co RevenueStandard Chem & Pharm Co EBITStandard Chem & Pharm Co Net Income
2024e6.94 B undefined1.44 B undefined907.7 M undefined
20236.24 B undefined1.26 B undefined834.89 M undefined
20225.85 B undefined1.12 B undefined815.41 M undefined
20214.6 B undefined876.68 M undefined706.73 M undefined
20204.31 B undefined706.59 M undefined524.17 M undefined
20193.94 B undefined515.84 M undefined376.48 M undefined
20183.57 B undefined388.26 M undefined374.36 M undefined
20173.85 B undefined541.48 M undefined363.29 M undefined
20163.67 B undefined418.14 M undefined340.22 M undefined
20153.32 B undefined383.49 M undefined347.89 M undefined
20143.3 B undefined374.69 M undefined374.24 M undefined
20133.05 B undefined265.2 M undefined298.4 M undefined
20123.37 B undefined214.6 M undefined271.4 M undefined
20113.33 B undefined207.5 M undefined246.7 M undefined
20102.89 B undefined323.3 M undefined210.1 M undefined
20092.28 B undefined302.7 M undefined293.5 M undefined
20082.18 B undefined332.9 M undefined274.6 M undefined
20072.01 B undefined305.2 M undefined267.7 M undefined
20061.92 B undefined357.4 M undefined323.4 M undefined
20051.68 B undefined328.6 M undefined278.8 M undefined
20041.52 B undefined230.5 M undefined203.2 M undefined

Standard Chem & Pharm Co stock margins

The Standard Chem & Pharm Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Standard Chem & Pharm Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Standard Chem & Pharm Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Standard Chem & Pharm Co's sales revenue. A higher gross margin percentage indicates that the Standard Chem & Pharm Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Standard Chem & Pharm Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Standard Chem & Pharm Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Standard Chem & Pharm Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Standard Chem & Pharm Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Standard Chem & Pharm Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Standard Chem & Pharm Co Margin History

Standard Chem & Pharm Co Gross marginStandard Chem & Pharm Co Profit marginStandard Chem & Pharm Co EBIT marginStandard Chem & Pharm Co Profit margin
2024e43.68 %20.74 %13.08 %
202343.68 %20.19 %13.38 %
202242.51 %19.11 %13.94 %
202144.91 %19.04 %15.35 %
202044.59 %16.41 %12.17 %
201943.41 %13.1 %9.56 %
201843.23 %10.87 %10.48 %
201745.44 %14.07 %9.44 %
201642.91 %11.38 %9.26 %
201545.01 %11.55 %10.47 %
201443.93 %11.37 %11.36 %
201342.49 %8.68 %9.77 %
201238.97 %6.36 %8.04 %
201139.98 %6.23 %7.4 %
201042.49 %11.17 %7.26 %
200945.92 %13.25 %12.85 %
200848.73 %15.26 %12.58 %
200750.88 %15.17 %13.31 %
200652.56 %18.57 %16.81 %
200553.16 %19.6 %16.63 %
200451.91 %15.21 %13.41 %

Standard Chem & Pharm Co Aktienanalyse

What does Standard Chem & Pharm Co do?

The Standard Chem & Pharm Co Ltd is a company specializing in the production and sale of pharmaceutical and chemical products. The company has a long history and was founded in 1900. Since then, it has become one of the leading companies in the industry. The business model of Standard Chem & Pharm Co Ltd is based on the manufacture and sale of high-quality pharmaceutical and chemical products. The company specializes in the production of medicines and specialty chemicals, and also offers other chemical products. The company's goal is to produce high-quality products that meet the requirements and needs of customers. Standard Chem & Pharm Co Ltd has several divisions that focus on different areas. One of the main divisions of the company is the pharmaceutical division. In this division, the company specializes in the production of medicines used to treat various diseases. The company produces medicines for various diseases such as cardiovascular diseases, diabetes, oncology, neurology, and many others. Another division of the company is the chemical division. In this division, Standard Chem & Pharm Co Ltd manufactures various chemical products used in many industrial applications. These products include dyes, solvents, plastics, resins, paints, and many other chemical products. The company also offers products for the agricultural science sector. The company produces fertilizers, pesticides, and herbicides used in agriculture to promote plant growth and increase crop yields. In addition to these products, the company also offers other specialized products, such as reagents for laboratory analysis and products for the production of cosmetics and hygiene articles. Standard Chem & Pharm Co Ltd is known for the high quality of its products and strict adherence to international standards. The company places great importance on research and development to continuously develop and bring innovative products to the market. It continuously invests in modern technology and state-of-the-art facilities to ensure the highest quality and efficiency in production. Overall, Standard Chem & Pharm Co Ltd has a long and successful history in the production and sale of pharmaceutical and chemical products. The company takes pride in producing high-quality products that meet the requirements and needs of its customers. The company will continue to invest in research and development to improve the production and quality of its products and remain successful in the market. Standard Chem & Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Standard Chem & Pharm Co's Sales Figures

The sales figures of Standard Chem & Pharm Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Standard Chem & Pharm Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Standard Chem & Pharm Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Standard Chem & Pharm Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Standard Chem & Pharm Co Stock

How much revenue did Standard Chem & Pharm Co generate this year?

Standard Chem & Pharm Co has achieved a revenue of 6.94 B TWD this year.

How much was the turnover of the company Standard Chem & Pharm Co compared to the previous year?

The revenue of Standard Chem & Pharm Co has increased by 11.21% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Standard Chem & Pharm Co?

The revenue of Standard Chem & Pharm Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Standard Chem & Pharm Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Standard Chem & Pharm Co so important for investors?

The revenue of Standard Chem & Pharm Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Standard Chem & Pharm Co pay?

Over the past 12 months, Standard Chem & Pharm Co paid a dividend of 2.5 TWD . This corresponds to a dividend yield of about 3.37 %. For the coming 12 months, Standard Chem & Pharm Co is expected to pay a dividend of 2.5 TWD.

What is the dividend yield of Standard Chem & Pharm Co?

The current dividend yield of Standard Chem & Pharm Co is 3.37 %.

When does Standard Chem & Pharm Co pay dividends?

Standard Chem & Pharm Co pays a quarterly dividend. This is distributed in the months of August, August, August, September.

How secure is the dividend of Standard Chem & Pharm Co?

Standard Chem & Pharm Co paid dividends every year for the past 21 years.

What is the dividend of Standard Chem & Pharm Co?

For the upcoming 12 months, dividends amounting to 2.5 TWD are expected. This corresponds to a dividend yield of 3.37 %.

In which sector is Standard Chem & Pharm Co located?

Standard Chem & Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Standard Chem & Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Standard Chem & Pharm Co from 8/31/2023 amounting to 2.5 TWD, you needed to have the stock in your portfolio before the ex-date on 8/4/2023.

When did Standard Chem & Pharm Co pay the last dividend?

The last dividend was paid out on 8/31/2023.

What was the dividend of Standard Chem & Pharm Co in the year 2023?

In the year 2023, Standard Chem & Pharm Co distributed 2.5 TWD as dividends.

In which currency does Standard Chem & Pharm Co pay out the dividend?

The dividends of Standard Chem & Pharm Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Standard Chem & Pharm Co

Our stock analysis for Standard Chem & Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Standard Chem & Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.